Personalized medicine and blood disorders

Personalized Medicine
Li Zhang

Abstract

Personalized medicine has been using genomics approaches to elucidate the etiology of a disease as well as to personalize the management for patients of a particular disease based on that individual's genetic features. It benefits patients across a multitude of therapeutic areas and advancements are particularly evident in hematology/oncology. The importance of genomics discoveries and development in nonmalignant blood disorders generally goes unrecognized, but it becomes critical now due to the global disease burden and a high mortality. This paper focuses on the exploration of personalized medicine applications in hemoglobin diseases, and thrombotic and bleeding disorders. It discusses the challenges which slow down the implementation as well. The available data suggest that the ability to understand the clinical features of a patient's genetic profile and the knowledge of disease mechanisms are the keys to facilitate new diagnosis, new therapies, new prescriptions and better healthcare.

References

Jul 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Annarita MiccioGiuliana Ferrari
Jan 26, 2010·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Antonio Cao, Renzo Galanello
Mar 24, 2010·Annals of Hematology·Anke K BergmannEllis J Neufeld
Jun 17, 2010·The New England Journal of Medicine·Margaret A Hamburg, Francis S Collins
Jan 15, 2011·Journal of the National Comprehensive Cancer Network : JNCCN·Robin K KelleyAlan P Venook
Feb 4, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Paula D James, Anne C Goodeve
Mar 3, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·J N LozierI Menashe
Apr 15, 2011·Blood·Idowu AkinsheyeMartin H Steinberg
Nov 23, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·C H MillerUNKNOWN Hemophilia Inhibitor Research Study Investigators
Jun 29, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·P W Collins
Apr 24, 2013·Therapeutic Advances in Hematology·Char Witmer, Guy Young
May 23, 2013·Blood·Franco LocatelliUNKNOWN Eurocord and European Blood and Marrow Transplantation (EBMT) group
Jul 3, 2013·American Journal of Hematology·Flora PeyvandiAnastassios D Retzios
Aug 9, 2013·Blood·Corien L EckhardtUNKNOWN INSIGHT Study Group
Oct 12, 2013·The Journal of Pathology·Simon A SmithSimon J Hollingsworth
Oct 29, 2014·Computational and Structural Biotechnology Journal·Gayane Badalian-Very
Feb 26, 2015·Blood·Roberta PallaAmy D Shapiro
Jul 8, 2015·Journal of Thrombosis and Haemostasis : JTH·P E Monahan
Jul 17, 2015·American Journal of Hematology·Natasha ArcherCarlo Brugnara
Sep 1, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Roland W Herzog
Sep 17, 2015·Nature·Matthew C CanverDaniel E Bauer
Dec 23, 2015·Pharmaceutics·Li Zhang, Huixiao Hong
Jan 26, 2016·Seminars in Hematology·Lindsey A George, Patrick F Fogarty
Jan 29, 2016·Haematologica·Andreas EngertUNKNOWN EHA Roadmap for European Hematology Research
Feb 6, 2016·Blood·Srikanth Nagalla, Paul F Bray
Feb 24, 2016·Expert Opinion on Orphan Drugs·Valder R Arruda, Ben J Samelson-Jones
Apr 9, 2016·Blood·Jason A Taylor, Rebecca Kruse-Jarres
Apr 24, 2016·Biomedical Journal·Edouard de DreuzyEmmanuel Payen
Jun 25, 2016·Human Molecular Genetics·Elenoe C Smith, Stuart H Orkin
Jul 8, 2016·PloS One·Suella MartinoUNKNOWN French Reference Center for Thrombotic Microangiopathies
Dec 13, 2018·The EPMA Journal·Judita Kinkorová, Ondřej Topolčan

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
genotyping
exome sequencing

Clinical Trials Mentioned

NCT02140554
NCT02151526
NCT01745120
NCT02453477
NCT02247843
NCT02186418
NCT01639690
NCT01257269
NCT02216084

Software Mentioned

Bluebird Bio

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Family Planning Perspectives
International Journal of Stroke : Official Journal of the International Stroke Society
Peter A G Sandercock
Biomarkers in Medicine
Jose D Herazo-Maya, Naftali Kaminski
Discovery Medicine
Luisa Mestroni, Matthew R G Taylor
Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Wei Huang, Xian-yao Wan
© 2022 Meta ULC. All rights reserved